Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Connecticut for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Connecticut only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Connecticut (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

John Huang (NPI 1801822754)

Field	Value
Entity Type	Individual
Organization	John Huang
Address	85 Seymour St
City	Hartford
State	CT
ZIP	06106
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 23, 2006

Payer Source	Total Paid
Medicare	$2M
Medicaid	$0

Key Findings

This provider’s Medicare billing is concentrated in retina-focused, procedural ophthalmology: J0178 (Injection, aflibercept) alone accounts for $1.1M in revenue and 1.6K claims (54.9% of Medicare revenue), and other high-volume procedure and imaging codes such as 67028 (intravitreal injection) with $140.9K and 1.3K claims and 92134 (retinal imaging/OCT) with $87.9K and 2.6K claims together reflect a practice model organized around frequent intravitreal therapy and serial retinal assessment. The presence of high-volume therapeutic injections plus diagnostic OCT is consistent with a retina clinic treating chronic retinal disease requiring repeated visits.

Top-line revenue concentration is pronounced: the precomputed top-3 codes account for 70.5% of this provider's total Medicare revenue, driven by J0178 ($1.1M, 54.9%), J2777 ($175.7K, 8.6%), and 99214 ($141.8K, 7.0%). This concentration indicates that a small number of drug and evaluation codes dominate Medicare dollars for this provider, creating material dependence on intravitreal drug administration and associated follow-up visits.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $2M while there is no Medicaid billing on file. The absence of Medicaid activity suggests limited exposure to that payer and that any analyses of access, utilization, or financial risk should be centered on Medicare experience.

Competitive standing is mixed by code: J0178 ranks #736 of 3204 providers nationally (77th percentile; typical, unremarkable volume for this code) and 67028 ranks #992 of 4255 (77th percentile; typical, unremarkable volume), indicating typical national participation in aflibercept administration and intravitreal procedures, while 99214 is a notable outlier—ranking #5178 of 479517 providers nationally (99th percentile; extreme outlier, far above typical national volume). This suggests the provider operates a higher-than-typical office visit volume relative to most Medicare ophthalmologists even while their drug-administration volumes are within a more typical range.

Several codes are statistical outliers on utilization: 99214 (1.3K claims, $141.8K) is labeled an "extreme outlier, far above typical national volume," and 92134 (2.6K claims, $87.9K) is also labeled an "extreme outlier, far above typical national volume." Those elevated E/M and OCT volumes imply a workflow that generates frequent, moderate-complexity visits and high-throughput imaging, consistent with management of chronic retinal conditions.

The provider’s drug mix shows use of multiple intravitreal agents and biosimilars: beyond J0178 ($1.1M) the file includes J2777 ($175.7K), J2778 ($66.2K), J2781 ($39.7K), Q5128 ($27.7K) and J9035 ($27.5K). This spread of revenue across branded agents, biosimilars, and other injected drugs indicates a clinically diverse therapeutic approach rather than exclusive reliance on a single agent.

Operationally, the practice appears to run a high-throughput injection clinic: 1.3K claims for 67028 (intravitreal injection) and 1.3K claims for 99214 (moderate-complexity established patient visits) point to frequent procedure episodes paired with same-day or serial evaluation visits. That combination supports a workflow optimized for recurring procedures and follow-up care rather than episodic surgical retina or low-frequency subspecialty work.

The provider has a long tenure in the NPI registry (NPI enumerated 2006-06-23 (~20 years ago)), signaling an established clinical presence. Given the long enumeration and the concentrated, repeat-care revenue profile, the practice model appears to be a sustained retina-focused outpatient operation with mature referral and follow-up patterns.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

22 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,630	$690	$1.1M
J2777	Injection, faricimab‑svoa, 0.1 mg	6,060	$30	$175.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,340	$110	$141.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,320	$110	$140.9K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,010	$100	$102.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,590	$30	$87.9K
J3490	Unclassified drugs	40	$1,890	$69.9K
J2778	Injection, ranibizumab, 0.1 mg	360	$180	$66.2K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	330	$120	$39.7K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	130	$220	$27.7K

Showing 1–10 of 22

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Connecticut Distribution

John Huang — 4 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Connecticut

Full comparison — all codes billed, vs. state median

22 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	7	40	830	$690	$713.1K
J2777	21	30	8,190	$30	$340.4K
J2778	9	20	410	$180	$117.8K
Q5128	5	10	300	$220	$105.2K
J3490	16	20	50	$1,380	$76K
67028	8	50	540	$100	$66.4K
J2781	10	10	440	$120	$55.7K
92014	10	580	100	$90	$18.6K
92012	272	300	120	$70	$15.2K
92235	20	30	40	$110	$14.8K

Showing 1–10 of 22

Related Providers

Other providers that share a Tax Identification Number (TIN) with John Huang, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Refocus Eye Health Of Central Connecticut, P.C.	CT	Ophthalmology Physician	$0	$8.2M
David Tom	CT	Ophthalmology Physician	$2.5M	$0
Jerry Tsong	CT	Ophthalmology Physician	$1.9M	$0
Erol Verter	CT	Ophthalmology Physician	$1.7M	$0
Gregory Haffner	CT	Ophthalmology Physician	$1.4M	$0
Neil Kalbag	CT	Ophthalmology Physician	$1.1M	$0
Edward Fitzpatrick	CT	Ophthalmology Physician	$757.6K	$0
Patrick Coady	NJ	Ophthalmology Physician	$728.9K	$0
Rebecca Shields	NY	Ophthalmology Physician	$319.3K	$331.6K
Neal Adams	MD	Ophthalmology Physician	$497.9K	$5.3K

Nearby Providers

Other providers in the same ZIP code as John Huang, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Connecticut Children's Medical Center	CT	Children's Hospital	$0	$248.8M
Hartford Dispensary	CT	Substance Use Disorder Rehabilitation Clinic/Center	$1.6M	$122.8M
Connecticut Children's Specialty Group, Inc.	CT	Pediatrics Physician	$0	$59.8M
Hartford Healthcare Medical Group Specialists, PLLC	CT	Surgery Physician	$0	$46M
Charter Oak Health Center, Inc.	CT	Federally Qualified Health Center (FQHC)	$0	$42.5M
Hartford Dispensary	CT	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$26.1M
Aetna Ambulance Service, Inc	CT	Land Ambulance	$2.9M	$22.2M
Home Care Vna, LLC	CT	Home Health Agency	$0	$12.4M
Connecticut Gi PLLC	CT	Gastroenterology Physician	$0	$12M
Charter Oak Health Center, Inc.	CT	Federally Qualified Health Center (FQHC)	$0	$8M

John Huang — Billing Profile & Reimbursement Data

Sign up for John Huang — Billing Profile & Reimbursement Data policy alerts

John Huang — Billing Profile & Reimbursement Data

Sign up for John Huang — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References